TrialDiabetes, obesity & metabolism2017

Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.

Pelle L Ishøy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.